Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Targanta Therapeutics: Hitting a Moving Target, Teaching Note
Daemmrich, Arthur A.Nota del Instructor HBS-710006-EIniciativa emprendedoraTeaching Note for [709002].Desde 0,00 €
-
Targanta Therapeutics: Hitting a Moving Target (PPT)
Daemmrich, Arthur A.Caso HBS-711056-EIniciativa emprendedoraDesde 8,20 €
-
A Managerial Perspective on Clinical Trials
Daemmrich, Arthur A.Caso HBS-709033-EIniciativa emprendedoraThis note describes the history and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven years, and consumes up to 70 percent of a drug's total development costs, pharmaceutical and biotechnology leaders need to understand clinical trial management. Likewise, with a growing variety of new product i...Desde 8,20 €
-
Targanta Therapeutics: Hitting a Moving Target
Daemmrich, Arthur A.Caso HBS-709002-EIniciativa emprendedoraThis case explores regulatory, product testing, and business strategy at Targanta Therapeutics, a biotech company preparing its first new drug application to the FDA. In October 2007, Mark Leuchtenberger, president and CEO of Targanta - which has just held a successful IPO - weighs options for the approximately ten month review period after the company submits to the Food and Drug Administration. The case reviews Targanta's origins and "de-riskin...Desde 8,20 €